Patents Assigned to SIT Biotech GmbH
  • SELECTIVE CELL DEATH-INDUCING ENZYME SYSTEM
    Publication number: 20220370555
    Abstract: The invention relates to a fusion protein containing a selective cell death-inducing enzyme system for use in the therapy and/or treatment of cancer and tumors in humans and animals, a process, and its use.
    Type: Application
    Filed: March 13, 2018
    Publication date: November 24, 2022
    Applicant: SIT Biotech GmbH
    Inventors: Sylvain TOUREL, Tabea KRÄFT